Ginsenoside-Rb1 Attenuates Dilated Cardiomyopathy in cTnTR141W Transgenic Mouse
Familial dilated cardiomyopathy (FDCM) is caused by defective genes and specific medicines are not currently available to treat this. Ginsenoside-Rb1 provides cardioprotection in the experimental models of myocardial ischemia–reperfusion injury. Here we investigate Rb1’s effect on DCM in cTnTR141W t...
Main Authors: | Haiping Zhao, Dan Lv, Wei Zhang, Wei Dong, Juan Feng, Zhiguang Xiang, Lan Huang, Chuan Qin, Lianfeng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319310242 |
Similar Items
-
Ginsenoside Rb1 Protects Against Diabetic Cardiomyopathy by Regulating the Adipocytokine Pathway
by: Zhang C, et al.
Published: (2022-01-01) -
Progress of Ginsenoside Rb1 in neurological disorders
by: Gongxia Ling, et al.
Published: (2024-01-01) -
Progress in the Conversion of Ginsenoside Rb1 into Minor Ginsenosides Using β-Glucosidases
by: Hongrong Zhu, et al.
Published: (2023-01-01) -
Investigation of a transgenic mouse model of familial dilated cardiomyopathy.
by: Song, W, et al.
Published: (2010) -
Gene-Targeted Mice with the Human Troponin T R141W Mutation Develop Dilated Cardiomyopathy with Calcium Desensitization.
by: Mohun Ramratnam, et al.
Published: (2016-01-01)